연구동향 분석

REVIEW : Recent technological updates and clinical applications of induced pluripotent stem cells

( Sebastian Diecke ) ( Seung Min Jung ) ( Jae Cheol Lee ) ( Ji Hyeon Ju ) 2014년

논문상세정보
인용/피인용
' REVIEW : Recent technological updates and clinical applications of induced pluripotent stem cells' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • diseasemodel
  • geneediting
  • induced pluripotent stem cells
  • regenerative medicine
  • reprogrammingtechnique
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
68 0

0.0%

' REVIEW : Recent technological updates and clinical applications of induced pluripotent stem cells' 의 참고문헌

  • Vascularized and functional human liver from an iPSC-derived organ bud transplant
    Takebe T Nature 499 : 481 ~ 484 [2013]
  • Vaccinia virus B18R gene encodes a type I interferon-binding protein that blocks interferon alpha transmembrane signaling
    Colamonici OR J Biol Chem 270 : 15974 ~ 15978 - [1995]
  • Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome
    Yazawa M Nature 471 : 230 ~ 234 - [2011]
  • Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin
    Hanna J Science 318 : 1920 ~ 1923 - [2007]
  • Translation of stem cell research: points to consider in designing preclinical animal studies
    Frey-Vasconcells J Stem Cells Transl Med 1 : 353 ~ 358 - [2012]
  • The promise of induced pluripotent stem cells in research and therapy
    Robinton DA Nature 481 : 295 ~ 305 - [2012]
  • The extragenic spacer length between the 5’ and 3’ ends of the transgene expression cassette affects transgene silencing from plasmid-based vectors
    Lu J Mol Ther 20 : 2111 ~ 2119 - [2012]
  • Technological overview of iPS induction from human adult somatic cells
    Bayart E Curr Gene Ther 13 : 73 ~ 92 - [2013]
  • Technical challenges in using human induced pluripotent stem cells to model disease
    Saha K Cell Stem Cell 5 : 584 ~ 595 - [2009]
  • Systematic review of induced pluripotent stem cell technology as a potential clinical therapy for spinal cord injury
    Kramer AS Cell Transplant 22 : 571 ~ 617 - [2013]
  • Stem cells: a view from the roots
    Somorjai IM Biotechnol J 7 : 704 ~ 722 - [2012]
  • Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming
    Jaenisch R Cell 132 : 567 ~ 582 - [2008]
  • Small molecules in stem cell self-renewal and differentiation
    Schugar RC Gene Ther 15 : 126 ~ 135 - [2008]
  • Reprogramming human fibroblasts to pluripotency using modified mRNA
    Mandal PK Nat Protoc 8 : 568 ~ 582 - [2013]
  • Polycistronic lentiviral vector for “hit and run” reprogramming of adult skin fibroblasts to induced pluripotent stem cells
    Chang CW Stem Cells 27 : 1042 ~ 1049 - [2009]
  • Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds
    Hou P Science 341 : 651 ~ 654 - [2013]
  • Patient-specif ic induced pluripotent stem-cell-derived models of LEOPARD syndrome
    Carvajal-Vergara X Nature 465 : 808 ~ 812 - [2010]
  • No evidence for infection of human embryonic stem cells by feeder cell-derived murine leukemia viruses
    Amit M Stem Cells 23 : 761 ~ 771 - [2005]
  • Neurons derived from reprogrammed f ibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson’s disease
    Wernig M Proc Natl Acad Sci U S A 105 : 5856 ~ 5861 - [2008]
  • Molecules that promote or enhance reprogramming of somatic cells to induced pluripotent stem cells
    Feng B Cell Stem Cell 4 : 301 ~ 312 - [2009]
  • Modelling the long QT syndrome with induced pluripotent stem cells
    Itzhaki I Nature 471 : 225 ~ 229 [2011]
  • Modelling schizophrenia using human induced pluripotent stem cells
    Brennand KJ Nature 473 : 221 ~ 225 - [2011]
  • Modeling for Lesch-Nyhan disease by gene targeting in human embryonic stem cells
    Urbach A Stem Cells 22 : 635 ~ 641 - [2004]
  • Minicircle DNA vectors devoid of bacterial DNA result in persistent and high-level transgene expression in vivo
    Chen ZY Mol Ther 8 : 495 ~ 500 - [2003]
  • MicroRNAs and stem cells:control of pluripotency, reprogramming, and lineage commitment
    Heinrich EM Circ Res 110 : 1014 ~ 1022 - [2012]
  • Methods for making induced pluripotent stem cells: reprogramming a la carte
    Gonzalez F Nat Rev Genet 12 : 231 ~ 242 - [2011]
  • Maintenance of Epstein–Barr virus (EBV)oriP-based episomes requires EBV-encoded nuclear antigen-1 chromosome-binding domains, which can be replaced by high-mobility group-I or histone H1
    Hung SC Proc Natl Acad Sci U S A 98 : 1865 ~ 1870 - [2001]
  • Investigating monogenic and complex diseases with pluripotent stem cells
    Zhu H Nat Rev Genet 12 : 266 ~ 275 - [2011]
  • Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors
    Takahashi K Cell 126 : 663 ~ 676 - [2006]
  • Induction of pluripotent stem cells from adult human fibroblasts by defined factors
    Takahashi K Cell 131 : 861 ~ 872 - [2007]
  • Induction of pluripotency: from mouse to human
    Zaehres H Cell 131 : 834 ~ 835 - [2007]
  • Induced pluripotent stem cells: opportunities for disease modelling and drug discovery
    Grskovic M Nat Rev Drug Discov 10 : 915 ~ 929 - [2011]
  • Induced pluripotent stem cells generated without viral integration
    Stadtfeld M Science 322 : 945 ~ 949 - [2008]
  • Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons
    Dimos JT Science 321 : 1218 ~ 1221 - [2008]
  • Induced pluripotent stem cell models from X-linked adrenoleukodystrophy patients
    Jang J Ann Neurol 70 : 402 ~ 409 [2011]
  • Induced pluripotent stem cell lines derived from human somatic cells
    Yu J Science 318 : 1917 ~ 1920 - [2007]
  • Induced pluripotency:history, mechanisms, and applications
    Stadtfeld M Genes Dev 24 : 2239 ~ 2263 - [2010]
  • Immunological considerations for embryonic and induced pluripotent stem cell banking
    Taylor CJ Philos Trans R Soc Lond B Biol Sci 366 : 2312 ~ 2322 - [2011]
  • Human induced pluripotent stem cells free of vector and transgene sequences
    Yu J Science 324 : 797 ~ 801 - [2009]
  • Human iPSC-based modeling of late-onset disease via progerin-induced aging
    Miller JD Cell Stem Cell 13 : 691 ~ 705 - [2013]
  • Homologous recombination in human embryonic stem cells
    Zwaka TP Nat Biotechnol 21 : 319 ~ 321 - [2003]
  • Histone deacetylase inhibitors in cell pluripotency, differentiation, and reprogramming
    Kretsovali A Stem Cells Int 2012 : 184154 ~ [2012]
  • Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA
    Warren L Cell Stem Cell 7 : 618 ~ 630 - [2010]
  • Haplotype-based banking of human pluripotent stem cells for transplantation: potential and limitations
    Zimmermann A Stem Cells Dev 21 : 2364 ~ 2373 - [2012]
  • HLA-matching potential of an established human embryonic stem cell bank in China
    Lin G Cell Stem Cell 5 : 461 ~ 465 - [2009]
  • Genome engineering of mammalian haploid embryonic stem cells using the Cas9/RNA system
    Horii T PeerJ 1 : e230 ~ - [2013]
  • Genome editing in induced pluripotent stem cells
    Cheng LT Genes Cells 17 : 431 ~ 438 - [2012]
  • Generation of mouse-induced pluripotent stem cells by transient expression of a single nonviral polycistronic vector
    Gonzalez F Proc Natl Acad Sci U S A 106 : 8918 ~ 8922 - [2009]
  • Generation of mouse induced pluripotent stem cells without viral vectors
    Okita K Science 322 : 949 ~ 953 - [2008]
  • Generation of integration-free human induced pluripotent stem cells from postnatal blood mononuclear cells by plasmid vector expression
    Dowey SN Nat Protoc 7 : 2013 ~ 2021 - [2012]
  • Generation of induced pluripotent stem cells using recombinant proteins
    Zhou H Cell Stem Cell 4 : 381 ~ 384 - [2009]
  • Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins
    Kim D Cell Stem Cell 4 : 472 ~ 476 - [2009]
  • Generation of adult human induced pluripotent stem cells using nonviral minicircle DNA vectors
    Narsinh KH Nat Protoc 6 : 78 ~ 88 - [2011]
  • Generating an iPSC bank for HLA-matched tissue transplantation based on known donor and recipient HLA types
    Taylor CJ Cell Stem Cell 11 : 147 ~ 152 - [2012]
  • Feeder-free derivation of human induced pluripotent stem cells with messenger RNA
    Warren L Sci Rep 2 : 657 ~ - [2012]
  • Embryonic stem cells: overcoming the immunological barriers to cell replacement therapy
    Lui KO Curr Stem Cell Res Ther 4 : 70 ~ 80 - [2009]
  • Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases
    Hockemeyer D Nat Biotechnol 27 : 851 ~ 857 - [2009]
  • Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome
    Fusaki N Proc Jpn Acad Ser B Phys Biol Sci 85 : 348 ~ 362 - [2009]
  • Efficient generation of transgene-free human induced pluripotent stem cells (iPSCs) by temperature-sensitive Sendai virus vectors
    Ban H Proc Natl Acad Sci U S A 108 : 14234 ~ 14239 - [2011]
  • Efficient generation of human iPSCs by a synthetic self-replicative RNA
    Yoshioka N Cell Stem Cell 13 : 246 ~ 254 - [2013]
  • Diseases in a dish: modeling human genetic disorders using induced pluripotent cells
    Tiscornia G Nat Med 17 : 1570 ~ 1576 - [2011]
  • Disease-specific induced pluripotent stem cells
    Park IH Cell 134 : 877 ~ 886 - [2008]
  • Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution
    Maherali N Cell Stem Cell 1 : 55 ~ 70 - [2007]
  • Directed differentiation of pluripotent stem cells: from developmental biology to therapeutic applications
    Irion S Cold Spring Harb Symp Quant Biol 73 : 101 ~ 110 - [2008]
  • Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development
    Murry CE Cell 132 : 661 ~ 680 - [2008]
  • Differential modeling of fragile X syndrome by human embryonic stem cells and induced pluripotent stem cells
    Urbach A Cell Stem Cell 6 : 407 ~ 411 - [2010]
  • Comparison of treatment effects between animal experiments and clinical trials: systematic review
    Perel P BMJ 334 : 197 ~ [2007]
  • Characterization of human induced pluripotent stem cell-derived retinal pigment epithelium cell sheets aiming for clinical application
    Kamao H Stem Cell Reports 2 : 205 ~ 218 - [2014]
  • Cardiac Tissue Engineering: Methods and Protocols. Vol. 1181
    Diecke S Humana Press [2014]
  • Can the pharmaceutical industry reduce attrition rates?
    Kola I Nat Rev Drug Discov 3 : 711 ~ 715 - [2004]
  • California ponders cell-banking venture
    Hayden EC Nature 472 : 403 ~ - [2011]
  • An efficient nonviral method to generate integration-free human-induced pluripotent stem cells from cord blood and peripheral blood cells
    Okita K Stem Cells 31 : 458 ~ 466 - [2013]
  • Activation of innate immunity is required for efficient nuclear reprogramming
    Lee J Cell 151 : 547 ~ 558 - [2012]
  • A nonviral minicircle vector for deriving human iPS cells
    Jia F Nat Methods 7 : 197 ~ 199 - [2010]
  • A mini-intronic plasmid (MIP):a novel robust transgene expression vector in vivo and in vitro
    Lu J Mol Ther 21 : 954 ~ 963 - [2013]
  • A guide to genome engineering with programmable nucleases
    Kim H Nat Rev Genet 15 : 321 ~ 334 - [2014]
  • A TALEN genome-editing system for generating human stem cell-based disease models
    Ding Q Cell Stem Cell 12 : 238 ~ 251 - [2013]